Institution
Islamic Azad University
Education•Tehran, Iran•
About: Islamic Azad University is a education organization based out in Tehran, Iran. It is known for research contribution in the topics: Population & Catalysis. The organization has 83635 authors who have published 113437 publications receiving 1275049 citations. The organization is also known as: Azad University.
Topics: Population, Catalysis, Adsorption, Fuzzy logic, Nonlinear system
Papers published on a yearly basis
Papers
More filters
••
TL;DR: To assess current trajectories towards the GPW13 UHC billion target—1 billion more people benefiting from UHC by 2023—the authors estimated additional population equivalents with UHC effective coverage from 2018 to 2023, and quantified frontiers of U HC effective coverage performance on the basis of pooled health spending per capita.
304 citations
••
TL;DR: In this article, the authors explored the role of product and process innovation capabilities as two distinct mechanisms through which collaborative innovation networks improve new product performance and examined the contingent effects of absorptive capacity on the relationship between collaborative innovation network and the two innovation capability dimensions.
303 citations
••
TL;DR: An overview of the epidemic disease caused by SARS-CoV-2 called coronavirus disease-19, which has become a serious concern in the medical community, based on the current evidence is provided.
Abstract: In December 2019, a novel coronavirus, named Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) or (2019-nCoV) with unknown origin spread in Hubei province of China. The epidemic disease caused by SARS-CoV-2 called coronavirus disease-19 (COVID-19). The presence of COVID-19 was manifested by several symptoms, ranging from asymptomatic/mild symptoms to severe illness and death. The viral infection expanded internationally and WHO announced a Public Health Emergency of International Concern. To quickly diagnose and control such a highly infectious disease, suspicious individuals were isolated and diagnostic/treatment procedures were developed through patients’ epidemiological and clinical data. Early in the COVID-19 outbreak, WHO invited hundreds of researchers from around the world to develop a rapid quality diagnosis, treatment and vaccines, but so far no specific antiviral treatment or vaccine has been approved by the FDA. At present, COVID-19 is managed by available antiviral drugs to improve the symptoms, and in severe cases, supportive care including oxygen and mechanical ventilation is used for infected patients. However, due to the worldwide spread of the virus, COVID-19 has become a serious concern in the medical community. According to the current data of WHO, the number of infected and dead cases has increased to 8,708,008 and 461,715, respectively (Dec 2019 –June 2020). Given the high mortality rate and economic damage to various communities to date, great efforts must be made to produce successful drugs and vaccines against 2019-nCoV infection. For this reason, first of all, the characteristics of the virus, its pathogenicity, and its infectious pathways must be well known. Thus, the main purpose of this review is to provide an overview of this epidemic disease based on the current evidence.
303 citations
••
TL;DR: In this paper, a hybrid configuration of ant colony optimization (ACO) with artificial bee colony (ABC) algorithm called hybrid ACO-ABC algorithm is presented for optimal location and sizing of distributed energy resources (DERs) on distribution systems.
303 citations
••
TL;DR: This article summarizes exclusively scalable techniques and focuses on strengths and limitations with respect to the biomedical applicability and regulatory requirements concerning silver nanoparticles.
Abstract: Silver nanoparticles size makes wide range of new applications in various fields of industry. Synthesis of noble metal nanoparticles for applications such as catalysis, electronics, optics, environmental and biotechnology is an area of constant interest. Two main methods for Silver nanoparticles are the physical and chemical methods. The problem with these methods is absorption of toxic substances onto them. Green synthesis approaches overcome this limitation. Silver nanoparticles size makes wide range of new applications in various fields of industry. This article summarizes exclusively scalable techniques and focuses on strengths, respectively, limitations with respect to the biomedical applicability and regulatory requirements concerning silver nanoparticles.
301 citations
Authors
Showing all 83704 results
Name | H-index | Papers | Citations |
---|---|---|---|
Ajit Kumar Mohanty | 141 | 1124 | 93062 |
Pierluigi Paolucci | 138 | 1965 | 105050 |
Eric Conte | 132 | 1206 | 84593 |
Patrizia Azzi | 132 | 1275 | 83686 |
D. Del Re | 131 | 1406 | 87230 |
Jean-Laurent Agram | 128 | 1221 | 84423 |
Seyed Mohsen Etesami | 128 | 1101 | 76488 |
Jean-Charles Fontaine | 128 | 1190 | 84011 |
Roberta Arcidiacono | 128 | 1322 | 80917 |
Tejinder Virdee | 128 | 1208 | 74372 |
Frank Hartmann | 127 | 1116 | 81455 |
Paolo Azzurri | 126 | 1058 | 81651 |
Achim Stahl | 124 | 1248 | 111121 |
Federica Primavera | 120 | 876 | 63895 |
Riccardo Andrea Manzoni | 120 | 946 | 67897 |